查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1726274

全球電子藥物輸送設備市場：市場規模、佔有率、趨勢分析（按產品、應用和地區）、細分市場預測（2025-2030 年）

Electronic Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product (Implantable Drug Delivery Devices, Smart Metered Dose Inhalers), By Application (Diabetes, Oncology), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10個工作天內

價格

電子藥物傳輸設備市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球電子藥物輸送設備市場規模預計到2030年將達到995億美元，2025年至2030年期間的複合年成長率為8.14%。

這種成長可以歸因於老年人口的成長和慢性病的流行、個人化醫療意識的增強、居家醫療的日益普及以及數位技術的融合。例如，2024 年 6 月，AptarGroup, Inc. 與 SHL Medical 合作，將 Aptar Digital Health 的 SaMD 平台與 SHL Medical 的先進藥物輸送系統（包括自動注射器、筆式注射器和專用輸送系統）結合。

隨著患者越來越傾向於在家中管理自己的健康狀況，對能夠安全、有效和輕鬆地在家中進行治療的藥物輸送裝置的需求也日益增加。胰島素幫浦、自動注射器、穿戴式輸液幫浦和預填充式注射器等設備正在成為居家醫療的必備工具，因為它們允許患者在最少的幫助下自行用藥，既方便又自主。例如，2023 年 10 月，以其創新的 PEEK生醫材料而聞名的 Victrex plc 推出了其 VICTREX PC101 級產品，這是一款專為藥物輸送和藥物接觸應用而設計的先進產品。此次發布反映了家庭護理環境中藥物輸送設備日益成長的趨勢，增加了尋求創新解決方案的患者的可及性。

此外，由於對更高精度、個人化和患者便利性的需求，電子藥物輸送設備市場技術趨勢正在快速發展。新興趨勢包括數位健康技術的整合、穿戴式藥物傳輸設備以及微流體的使用。精準醫療的興起也正在推動技術創新。電子藥物傳輸裝置可以根據個人的基因組成、醫療狀況或特定的治療需求進行客製化，以確保更好的治療效果和更少的副作用。

電子藥物輸送設備市場：分析概述

  • 根據產品，植入式藥物輸送裝置佔據市場主導地位，2024 年的收入佔有率最大，為 33.0%，這得益於其減少副作用、控制藥物釋放和提供局部治療的能力。
  • 根據應用，糖尿病領域預計將在 2024 年佔據最大的收益佔有率。這是由於糖尿病盛行率高且患者數量不斷增加、糖尿病治療技術進步、市場需求不斷增加以及報銷支持。
  • 按地區分類，預計 2024 年北美將佔據最大的收益佔有率，超過 43.4%。這是由於技術進步、慢性病盛行率上升以及對以患者為中心的藥物輸送解決方案的需求不斷成長。

目錄

第1章 分析方法與範圍

第2章執行摘要

3. 電子藥物傳輸設備市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 關鍵科技趨勢
  • 主要品牌
  • 管道分析
  • 電子藥物輸送設備市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL分析

第4章電子藥物輸送設備市場：按產品分類的估計和趨勢分析

  • 細分儀表板
  • 電子藥物輸送設備市場：產品特定波動分析
  • 電子藥物傳輸設備市場：產品展望
  • 市場規模預測及趨勢分析（2018-2030年）
  • 智慧型輸液幫浦（輸液系統）
  • 智慧定量吸入器（吸入裝置）
  • 植入式藥物傳輸裝置

第5章電子藥物傳輸設備市場：按應用的估計和趨勢分析

  • 細分儀表板
  • 電子藥物傳輸設備市場：應用趨勢分析
  • 電子藥物傳輸設備市場：應用前景
  • 市場規模預測及趨勢分析（2018-2030年）
  • 糖尿病
  • 呼吸系統疾病
  • 腫瘤學
  • 心臟病學
  • 其他

第6章電子藥物傳輸設備市場：區域估計與趨勢分析

  • 區域儀表板
  • 電子藥物輸送設備市場：區域波動分析
  • 電子藥物輸送設備市場：區域估計與趨勢分析
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 市場參與企業分類
  • 主要企業簡介
    • Medtronic plc
    • Insulet Corporation
    • Becton, Dickinson and Company
    • Tandem Diabetes Care, Inc.
    • Ypsomed AG
    • Novo Nordisk A/S
    • Sanofi SA
    • Eli, Lilly and Company
    • AstraZeneca plc
    • GlaxoSmithKline plc
    • Boehringer Ingelheim International GmbH
    • Pfizer, Inc.
    • Teva Pharmaceutical Industries
    • Phillips-Medisize, LLC
    • West Pharmaceutical Services, Inc.
    • Gerresheimer AG
    • Nemera Group
    • SHL Group
    • Owen Mumford
    • Haselmeier AG
    • ICU Medical
    • Hisamitsu Pharmaceutical Co., Inc.
    • Sparsha Pharma International
    • Baxter International, Inc.
    • Fresenius Kabi AG
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Novartis AG
    • AptarGroup, Inc.
    • Teleflex Incorporates
    • Abbott Laboratories
Product Code: GVR-4-68040-556-9

Electronic Drug Delivery Devices Market Growth & Trends:

The global electronic drug delivery devices market size is anticipated to reach USD 99.5 billion by 2030 and is anticipated to grow at a CAGR of 8.14% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth can be attributed to the increasing the growing geriatric population and prevalence of chronic diseases, increasing awareness for personalized medicine, rising preference for home healthcare, and the integration of digital technologies. For instance, in June 2024, AptarGroup, Inc. collaborated with SHL Medical to integrate Aptar Digital Health's SaMD platform with SHL Medical's advanced drug delivery systems, such as autoinjectors, pen injectors, and specialty delivery systems.

As patients are increasingly preferring to manage their health conditions at home, there is a growing demand for drug delivery devices that enable safe, effective, and easy at-home treatments. Devices such as insulin pumps, auto-injectors, wearable infusion pumps, and pre-filled syringes are becoming indispensable tools in home healthcare because they allow patients to self-administer medications with minimal assistance, offering both convenience and autonomy. For instance, in October 2023, Victrex plc, known for its innovative PEEK biomaterial solutions, introduced an advanced product, the VICTREX PC101 grade, specifically designed for drug delivery and pharmaceutical contact applications. This launch aligns with the growing trend of utilizing drug delivery devices in homecare environments, enhancing accessibility for patients seeking innovative solutions.

Moreover, technology trends in the electronic drug delivery devices market are rapidly advancing, driven by the need for greater precision, personalization, and patient convenience. Some of the new trends include the integration of digital health technologies, wearable drug delivery devices, and the use of microfluidics. The rise of precision medicine is also driving innovation. The devices are being tailored to the individual's genetic makeup, condition, or specific therapeutic needs, ensuring better outcomes and fewer side effects.

Electronic Drug Delivery Devices Market Report Highlights:

  • Based on product, the implantable drug delivery devices segment dominated the market with the largest revenue share of 33.0% in 2024 owing to reduced side effects, controlled drug release, and their ability to provide localized treatment.
  • Based on application, the diabetes segment accounted for the largest revenue share in 2024 due to its high prevalence and growing patient population, technological advancements in diabetes care, growing market demand, and reimbursement support.
  • Based on region, North America held the largest revenue share of over 43.4% in 2024. This can be attributed to technological advancements, an increasing prevalence of chronic diseases, and rising demand for patient-centric drug delivery solutions.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Electronic Drug Delivery Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases and growing geriatric population
      • 3.2.1.2. Rising preference for home healthcare
      • 3.2.1.3. Integration of digital technologies and growing awareness of personalized medications
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of advanced drug delivery devices
      • 3.2.2.2. Limited patient awareness and device-related complications
  • 3.3. Key Technology Trends
  • 3.4. Key Brands
  • 3.5. Pipeline Analysis
  • 3.6. Electronic Drug Delivery Devices Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
      • 3.6.1.1. Bargaining power of suppliers
      • 3.6.1.2. Bargaining power of buyers
      • 3.6.1.3. Threat of substitutes
      • 3.6.1.4. Threat of new entrants
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTEL Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Economic landscape
      • 3.6.2.3. Social landscape
      • 3.6.2.4. Technological landscape
      • 3.6.2.5. Environmental landscape
      • 3.6.2.6. Legal landscape

Chapter 4. Electronic Drug Delivery Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Electronic Drug Delivery Devices Market: Product Movement Analysis
  • 4.3. Electronic Drug Delivery Devices Market by Product Outlook (Revenue, USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Smart Infusion Pumps (Infusion Systems)
    • 4.5.1. Smart Infusion Pumps (Infusion Systems) Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
      • 4.5.1.1. Non-biologic Smart Infusion Systems
        • 4.5.1.1.1. Non-biologic Smart Infusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
      • 4.5.1.2. Biologic Smart Infusion Systems
        • 4.5.1.2.1. Biologic Smart Infusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
          • 4.5.1.2.1.1. Smart Infusion Insulin Pumps
            • 4.5.1.2.1.1.1. Smart Infusion Insulin Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
          • 4.5.1.2.1.2. Others
            • 4.5.1.2.1.2.1. Others Market Revenue Estimated and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 4.6. Smart Metered Dose Inhalers (Inhalation Devices)
    • 4.6.1. Smart Metered Dose Inhalers (Inhalation Devices) Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 4.7. Implantable Drug Delivery Devices
    • 4.7.1. Implantable Drug Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
      • 4.7.1.1. Biologic Implantable Drug Delivery Devices
        • 4.7.1.1.1. Biologic Implantable Drug Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
      • 4.7.1.2. Non-biologic Implantable Drug Delivery Devices
        • 4.7.1.2.1. Non-biologic Implantable Drug Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 5. Electronic Drug Delivery Devices Market: Application Estimated & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Electronic Drug Delivery Devices Market: Application Movement Analysis
  • 5.3. Electronic Drug Delivery Devices Market by Application Outlook (Revenue, USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Diabetes
    • 5.5.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Respiratory Diseases
    • 5.6.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. Oncology
    • 5.7.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.8. Cardiology
    • 5.8.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Electronic Drug Delivery Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Regional Electronic Drug Delivery Devices Market Movement Analysis
  • 6.3. Electronic Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Product
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. North America
    • 6.5.1. North America Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. U.S. Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement scenario
      • 6.5.3.5. Canada Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement scenario
      • 6.5.4.5. Mexico Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Europe
    • 6.6.1. Europe Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. UK
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. UK Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. Germany Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.4. France
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement scenario
      • 6.6.4.5. France Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement scenario
      • 6.6.5.5. Italy Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement scenario
      • 6.6.6.5. Spain Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.7. Denmark
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement scenario
      • 6.6.7.5. Denmark Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Competitive Scenario
      • 6.6.8.3. Regulatory Framework
      • 6.6.8.4. Reimbursement scenario
      • 6.6.8.5. Sweden Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.9. Norway
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Competitive Scenario
      • 6.6.9.3. Regulatory Framework
      • 6.6.9.4. Reimbursement scenario
      • 6.6.9.5. Norway Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Asia Pacific Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Japan
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Japan Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. China
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. China Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. India
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. India Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. South Korea Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.6. Australia
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory Framework
      • 6.7.6.4. Reimbursement scenario
      • 6.7.6.5. Australia Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.7. Thailand
      • 6.7.7.1. Key Country Dynamics
      • 6.7.7.2. Competitive Scenario
      • 6.7.7.3. Regulatory Framework
      • 6.7.7.4. Reimbursement scenario
      • 6.7.7.5. Thailand Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.8. Latin America
    • 6.8.1. Latin America Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.8.2. Brazil
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement scenario
      • 6.8.2.5. Brazil Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement scenario
      • 6.8.3.5. Argentina Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.9. Middle East & Africa
    • 6.9.1. Middle East & Africa Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.9.2. South Africa
      • 6.9.2.1. Key Country Dynamics
      • 6.9.2.2. Competitive Scenario
      • 6.9.2.3. Regulatory Framework
      • 6.9.2.4. Reimbursement scenario
      • 6.9.2.5. South Africa Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.9.3. Saudi Arabia
      • 6.9.3.1. Key Country Dynamics
      • 6.9.3.2. Competitive Scenario
      • 6.9.3.3. Regulatory Framework
      • 6.9.3.4. Reimbursement scenario
      • 6.9.3.5. Saudi Arabia Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.9.4. UAE
      • 6.9.4.1. Key Country Dynamics
      • 6.9.4.2. Competitive Scenario
      • 6.9.4.3. Regulatory Framework
      • 6.9.4.4. Reimbursement scenario
      • 6.9.4.5. UAE Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.9.5. Kuwait
      • 6.9.5.1. Key Country Dynamics
      • 6.9.5.2. Competitive Scenario
      • 6.9.5.3. Regulatory Framework
      • 6.9.5.4. Reimbursement scenario
      • 6.9.5.5. Kuwait Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
    • 7.2.1. Medtronic plc
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Insulet Corporation
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Becton, Dickinson and Company
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Tandem Diabetes Care, Inc.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Ypsomed AG
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Novo Nordisk A/S
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Sanofi S.A.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Eli, Lilly and Company
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. AstraZeneca plc
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. GlaxoSmithKline plc
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Boehringer Ingelheim International GmbH
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Pfizer, Inc.
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Teva Pharmaceutical Industries
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Phillips-Medisize, LLC
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives
    • 7.2.15. West Pharmaceutical Services, Inc.
      • 7.2.15.1. Company overview
      • 7.2.15.2. Financial performance
      • 7.2.15.3. Product benchmarking
      • 7.2.15.4. Strategic initiatives
    • 7.2.16. Gerresheimer AG
      • 7.2.16.1. Company Overview
      • 7.2.16.2. Financial performance
      • 7.2.16.3. Product benchmarking
      • 7.2.16.4. Strategic initiatives
    • 7.2.17. Nemera Group
      • 7.2.17.1. Company overview
      • 7.2.17.2. Financial performance
      • 7.2.17.3. Product benchmarking
      • 7.2.17.4. Strategic initiatives
    • 7.2.18. SHL Group
      • 7.2.18.1. Company overview
      • 7.2.18.2. Financial performance
      • 7.2.18.3. Product benchmarking
      • 7.2.18.4. Strategic initiatives
    • 7.2.19. Owen Mumford
      • 7.2.19.1. Company overview
      • 7.2.19.2. Financial performance
      • 7.2.19.3. Product benchmarking
      • 7.2.19.4. Strategic initiatives
    • 7.2.20. Haselmeier AG
      • 7.2.20.1. Company overview
      • 7.2.20.2. Financial performance
      • 7.2.20.3. Product benchmarking
      • 7.2.20.4. Strategic initiatives
    • 7.2.21. ICU Medical
      • 7.2.21.1. Company overview
      • 7.2.21.2. Financial performance
      • 7.2.21.3. Product benchmarking
      • 7.2.21.4. Strategic initiatives
    • 7.2.22. Hisamitsu Pharmaceutical Co., Inc.
      • 7.2.22.1. Company overview
      • 7.2.22.2. Financial performance
      • 7.2.22.3. Product benchmarking
      • 7.2.22.4. Strategic initiatives
    • 7.2.23. Sparsha Pharma International
      • 7.2.23.1. Company overview
      • 7.2.23.2. Financial performance
      • 7.2.23.3. Product benchmarking
      • 7.2.23.4. Strategic initiatives
    • 7.2.24. Baxter International, Inc.
      • 7.2.24.1. Company overview
      • 7.2.24.2. Financial performance
      • 7.2.24.3. Product benchmarking
      • 7.2.24.4. Strategic initiatives
    • 7.2.25. Fresenius Kabi AG
      • 7.2.25.1. Company overview
      • 7.2.25.2. Financial performance
      • 7.2.25.3. Product benchmarking
      • 7.2.25.4. Strategic initiatives
    • 7.2.26. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 7.2.26.1. Company overview
      • 7.2.26.2. Financial performance
      • 7.2.26.3. Product benchmarking
      • 7.2.26.4. Strategic initiatives
    • 7.2.27. Novartis AG
      • 7.2.27.1. Company overview
      • 7.2.27.2. Financial performance
      • 7.2.27.3. Product benchmarking
      • 7.2.27.4. Strategic initiatives
    • 7.2.28. AptarGroup, Inc.
      • 7.2.28.1. Company overview
      • 7.2.28.2. Financial performance
      • 7.2.28.3. Product benchmarking
      • 7.2.28.4. Strategic initiatives
    • 7.2.29. Teleflex Incorporates
      • 7.2.29.1. Company overview
      • 7.2.29.2. Financial performance
      • 7.2.29.3. Product benchmarking
      • 7.2.29.4. Strategic initiatives
    • 7.2.30. Abbott Laboratories
      • 7.2.30.1. Company overview
      • 7.2.30.2. Financial performance
      • 7.2.30.3. Product benchmarking
      • 7.2.30.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 4 Global electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 5 North America electronic drug delivery devices market, by region, 2018 - 2030 (Revenue, USD Million)
  • Table 6 North America electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 7 North America electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 8 U.S electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 9 U.S electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 10 Canada electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 11 Canada electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 12 Mexico electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 13 Mexico electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 14 Europe electronic drug delivery devices market, by country, 2018 - 2030 (Revenue, USD Million)
  • Table 15 Europe electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 16 Europe electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 17 UK electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 18 UK electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 19 Germany electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 20 Germany electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 21 France electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 22 France electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 23 Italy electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 24 Italy electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 25 Spain electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 26 Spain electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 27 Norway electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 28 Norway electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 29 Sweden electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 30 Sweden electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 31 Denmark electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 32 Denmark electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 33 Asia Pacific electronic drug delivery devices market, by country, 2018 - 2030 (Revenue, USD Million)
  • Table 34 Asia Pacific electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 35 Asia Pacific electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 36 Japan electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 37 Japan electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 38 China electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 39 China electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 40 India electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 41 India electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 42 Australia electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 43 Australia electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 44 South Korea electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 45 South Korea electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 46 Thailand electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 47 Thailand electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 48 Latin America electronic drug delivery devices market, by country, 2018 - 2030 (Revenue, USD Million)
  • Table 49 Latin America electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 50 Latin America electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 51 Brazil electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 52 Brazil electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 53 Argentina electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 54 Argentina electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 55 Middle East & Africa electronic drug delivery devices market, by country, 2018 - 2030 (Revenue, USD Million)
  • Table 56 Middle East & Africa electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 57 Middle East & Africa electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 58 South Africa electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 59 South Africa electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 60 Saudi Arabia electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 61 Saudi Arabia electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 62 UAE electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 63 UAE electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 64 Kuwait electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 65 Kuwait electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Electronic drug delivery devices market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis by Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Electronic drug delivery devices market, product outlook key takeaways (Revenue, USD Million)
  • Fig. 12 Electronic drug delivery devices market: product movement analysis (Revenue, USD Million), 2023 & 2030
  • Fig. 13 Smart infusion pumps (infusion systems) market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 14 Non-biologic smart infusion systems market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 15 Biologic smart infusion systems market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 16 Smart infusion insulin pumps market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 17 Others market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 18 Smart metered dose inhalers (inhalation devices) market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 19 Implantable drug delivery devices market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 20 Biologic implantable drug delivery devices market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 21 Non-biologic implantable drug delivery devices market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 22 Smart transdermal patches (transdermal delivery systems) market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 23 Others market revenue estimates and forecasts, 2018 -2030 (Revenue, USD Million)
  • Fig. 24 Electronic drug delivery devices market, application outlook key takeaways (Revenue, USD Million)
  • Fig. 25 Electronic drug delivery devices market: application movement analysis (Revenue, USD Million), 2023 & 2030
  • Fig. 26 Diabetes market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 27 Respiratory Diseases market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 28 Oncology market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 29 Cardiology market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 30 Others market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 31 Electronic drug delivery devices market: Regional key takeaways (Revenue, USD Million)
  • Fig. 32 Electronic drug delivery devices market: regional outlook, 2023 & 2030, (Revenue, USD Million)
  • Fig. 33 North America electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 34 US electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 35 Canada electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 36 Mexico electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 37 Europe electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 38 UK electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 39 Germany electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 40 France electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 41 Spain electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 42 Italy electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 43 Sweden electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 44 Norway electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 45 Denmark electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 46 Asia Pacific electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 47 China electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 48 Japan electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 49 India electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million
  • Fig. 50 South Korea electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 51 Australia electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 52 Thailand electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 53 Latin America electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 54 Brazil electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 55 Argentina electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 56 Middle East and Africa electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 57 South Africa electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 58 Saudi Arabia electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 59 UAE electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 60 Kuwait electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 61 List of key emerging company's/technology disruptors/innovators